EA200801404A1 - Новый способ получения 5-амино-3н-тиазоло[4,5-d]пиримидин-2-она - Google Patents

Новый способ получения 5-амино-3н-тиазоло[4,5-d]пиримидин-2-она

Info

Publication number
EA200801404A1
EA200801404A1 EA200801404A EA200801404A EA200801404A1 EA 200801404 A1 EA200801404 A1 EA 200801404A1 EA 200801404 A EA200801404 A EA 200801404A EA 200801404 A EA200801404 A EA 200801404A EA 200801404 A1 EA200801404 A1 EA 200801404A1
Authority
EA
Eurasian Patent Office
Prior art keywords
pyrimidin
amino
tiazolo
obtaining
new method
Prior art date
Application number
EA200801404A
Other languages
English (en)
Inventor
Тингман Ванг
Джон С. Нг
Стефен Э. Веббер
Original Assignee
Анадис Фармасьютикалз, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Анадис Фармасьютикалз, Инк. filed Critical Анадис Фармасьютикалз, Инк.
Publication of EA200801404A1 publication Critical patent/EA200801404A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Настоящее изобретение относится к способу получения указанного целевого соединения, 5-амино-3H-тиазоло[4,5-d]пиримидин-2-она, представляющего собой полезное промежуточное соединение для получения некоторых тиазоло[4,5-d]пиримидиновых нуклеозидов, используемых в качестве иммуномодуляторов.
EA200801404A 2005-11-21 2006-11-20 Новый способ получения 5-амино-3н-тиазоло[4,5-d]пиримидин-2-она EA200801404A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73805505P 2005-11-21 2005-11-21
PCT/US2006/061111 WO2007062355A2 (en) 2005-11-21 2006-11-20 PROCESS FOR THE PREPARATION OF 5-AMINO-3H- THIAZOLO [4 , 5 -d] PYRIMIDIN- 2 -ONE

Publications (1)

Publication Number Publication Date
EA200801404A1 true EA200801404A1 (ru) 2008-10-30

Family

ID=37908057

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200801404A EA200801404A1 (ru) 2005-11-21 2006-11-20 Новый способ получения 5-амино-3н-тиазоло[4,5-d]пиримидин-2-она

Country Status (18)

Country Link
US (1) US7781581B2 (ru)
EP (1) EP1973920B1 (ru)
JP (1) JP5117391B2 (ru)
KR (1) KR20080090400A (ru)
CN (1) CN101365705A (ru)
AR (1) AR058210A1 (ru)
AT (1) ATE474842T1 (ru)
AU (1) AU2006318260B2 (ru)
BR (1) BRPI0618789A2 (ru)
CA (1) CA2630463C (ru)
DE (1) DE602006015700D1 (ru)
EA (1) EA200801404A1 (ru)
ES (1) ES2345904T3 (ru)
IL (1) IL191568A0 (ru)
NO (1) NO20082365L (ru)
SG (1) SG152296A1 (ru)
TW (1) TWI383987B (ru)
WO (1) WO2007062355A2 (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602007012247D1 (de) 2006-06-22 2011-03-10 Anadys Pharmaceuticals Inc Prodrugs von 5-amino-3-(3'-deoxy-beta-d-ribofuranosyl)-thiazolä4,5-düpyrimidin-2,7-dion
WO2012102366A1 (ja) * 2011-01-28 2012-08-02 日本たばこ産業株式会社 新規ピペラジン化合物の製造方法
CN103012284A (zh) * 2012-12-26 2013-04-03 无锡捷化医药科技有限公司 一种2-氨基-5-溴嘧啶类化合物的制备方法
AU2015359692B2 (en) 2014-12-08 2020-07-09 F. Hoffmann-La Roche Ag 3-substituted 5-amino-6H-thiazolo[4,5-d]pyrimidine-2,7-dione compounds for the treatment and prophylaxis of virus infection
CA3048768A1 (en) 2017-01-06 2018-07-12 F. Hoffmann-La Roche Ag Process for the preparation of 3-substituted 5-amino-6h-thiazolo[4,5-d]pyrimidine-2,7-dione compounds
CN111635368B (zh) * 2020-06-12 2021-06-29 东莞市东阳光仿制药研发有限公司 一种胺化合物的制备方法

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4643992A (en) 1982-11-09 1987-02-17 Scripps Clinic And Research Foundation Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives
US4539205A (en) 1982-11-09 1985-09-03 Scripps Clinic And Research Foundation Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives
US5166141A (en) 1983-11-01 1992-11-24 Scripps Clinic And Research Foundation Immunostimulating 7-deaza-7-oxa- and 7-deaza-7-oxo-analogs of 8-substituted-guanine-9-(1'-beta-D-aldoglycosidyl) derivatives and methods of treating test animals
US4746651A (en) 1983-11-01 1988-05-24 Scripps Clinic And Research Foundation Antimicrobial chemotherapeutic potentiation using substituted nucleoside derivatives
US5011828A (en) 1985-11-15 1991-04-30 Michael Goodman Immunostimulating guanine derivatives, compositions and methods
GB8712745D0 (en) 1987-05-30 1987-07-01 Wellcome Found Antiviral compounds
US5041426A (en) * 1987-12-21 1991-08-20 Brigham Young University Immune system enhancing 3-β-d-ribofuranosylthiazolo[4,5-d]pyridimine nucleosides and nucleotides
US4880784A (en) 1987-12-21 1989-11-14 Brigham Young University Antiviral methods utilizing ribofuranosylthiazolo[4,5-d]pyrimdine derivatives
US5041542A (en) 1988-06-03 1991-08-20 Nucleic Acid Research Institute Substituted pyrimido[5,4-d]pyrimidine nucleosides
GB9015914D0 (en) 1990-07-19 1990-09-05 Wellcome Found Heterocyclic compounds
US5248672A (en) 1990-11-01 1993-09-28 The Regents Of The University Of Michigan Polysubstituted benzimidazole nucleosides as antiviral agents
GB9105899D0 (en) 1991-03-20 1991-05-08 Wellcome Found Therapeutic nucleosides
AU5165793A (en) 1992-10-01 1994-04-26 Mcneilab, Inc. Derivatives of 7,8-disubstituted guanosines
GB9301000D0 (en) 1993-01-20 1993-03-10 Glaxo Group Ltd Chemical compounds
US5395937A (en) 1993-01-29 1995-03-07 Minnesota Mining And Manufacturing Company Process for preparing quinoline amines
US5446045A (en) 1993-12-20 1995-08-29 Revankar; Ganapathi R. Antiviral guanine analogs
US5994321A (en) 1993-12-20 1999-11-30 Aronex Pharmaceuticals, Inc. Antiviral guanine analogs
US5496816A (en) 1994-03-14 1996-03-05 Merck & Co., Inc. Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
AU698419B2 (en) 1996-07-03 1998-10-29 Dainippon Sumitomo Pharma Co., Ltd. A novel purine derivative
US6509320B1 (en) 1996-10-16 2003-01-21 Icn Pharmaceuticals, Inc. Purine L-nucleosides, analogs and uses thereof
KR100412480B1 (ko) 1996-10-16 2003-12-31 아이씨엔 파마슈티컬스, 인코포레이티드 푸린 ｌ-누클레오시드, 이의 유사체 및 이들의 용도
HUP9904665A3 (en) 1996-10-25 2000-11-28 Minnesota Mining And Mfg Co Sa Immune response modifier compounds for treatment of th2 mediated and related diseases
WO1999028321A1 (fr) 1997-11-28 1999-06-10 Sumitomo Pharmaceuticals Company, Limited Nouveaux composes heterocycliques
TW572758B (en) 1997-12-22 2004-01-21 Sumitomo Pharma Type 2 helper T cell-selective immune response inhibitors comprising purine derivatives
JP2002510695A (ja) * 1998-04-03 2002-04-09 デュポン ファーマシューティカルズ カンパニー 副腎皮質刺激ホルモン放出因子（ＣＲＦ）拮抗剤としてのチアゾロ［４，５−ｄ］ピリミジンおよびピリジン
US6444652B1 (en) 1998-08-10 2002-09-03 Novirio Pharmaceuticals Limited β-L-2'-deoxy-nucleosides for the treatment of hepatitis B
US6664264B2 (en) 2000-12-08 2003-12-16 3M Innovative Properties Company Thioether substituted imidazoquinolines
US6545017B1 (en) 2000-12-08 2003-04-08 3M Innovative Properties Company Urea substituted imidazopyridines
US6545016B1 (en) 2000-12-08 2003-04-08 3M Innovative Properties Company Amide substituted imidazopyridines
US6664260B2 (en) 2000-12-08 2003-12-16 3M Innovative Properties Company Heterocyclic ether substituted imidazoquinolines
US6667312B2 (en) 2000-12-08 2003-12-23 3M Innovative Properties Company Thioether substituted imidazoquinolines
US20020086871A1 (en) 2000-12-29 2002-07-04 O'neill Brian Thomas Pharmaceutical composition for the treatment of CNS and other disorders
DE60228229D1 (de) 2001-04-17 2008-09-25 Dainippon Sumitomo Pharma Co Neue adeninderivate
AU2002365412B2 (en) 2001-11-27 2008-10-09 Anadys Pharmaceuticals, Inc. 3-Beta-D-ribofuranosylthiazolo[4,5-d]pyrimidine nucleosides and uses thereof
US7321033B2 (en) 2001-11-27 2008-01-22 Anadys Pharmaceuticals, Inc. 3-B-D-ribofuranosylthiazolo [4,5-d] pyrimidine nucleosides and uses thereof
KR20050006221A (ko) 2002-05-06 2005-01-15 제네랩스 테크놀로지스, 인코포레이티드 Ｃ형 간염 바이러스 감염 치료용의 뉴클레오시드 유도체
US7196090B2 (en) * 2002-07-25 2007-03-27 Warner-Lambert Company Kinase inhibitors
US20050004144A1 (en) 2003-04-14 2005-01-06 Regents Of The University Of California Combined use of IMPDH inhibitors with toll-like receptor agonists
BRPI0411083A (pt) * 2003-06-12 2006-07-25 Astellas Pharma Inc derivado de benzamida ou sais do mesmo
ATE465742T1 (de) 2003-09-05 2010-05-15 Anadys Pharmaceuticals Inc Tlr7-liganden zur behandlung von hepatitis c
WO2005086904A2 (en) * 2004-03-08 2005-09-22 Amgen Inc. Therapeutic modulation of ppar (gamma) activity
ES2357015T3 (es) 2004-10-15 2011-04-15 Bayer Healthcare Llc Preparación y uso de derivados bifenil-4-ilcarbonilaminoácido para el tratamiento de la obesidad.
ES2525567T3 (es) * 2004-12-17 2014-12-26 Anadys Pharmaceuticals, Inc. Compuestos de 3H-oxazolo y 3H-tiazolo[4,5-d]pirimidin-2-ona 3,5-disustituidos y 3,5,7-trisustituidos y profármacos de los mismos
EP1888575A2 (en) 2005-05-09 2008-02-20 Hydra Biosciences, Inc. Compounds for modulating trpv3 function
DE602007012247D1 (de) 2006-06-22 2011-03-10 Anadys Pharmaceuticals Inc Prodrugs von 5-amino-3-(3'-deoxy-beta-d-ribofuranosyl)-thiazolä4,5-düpyrimidin-2,7-dion
BRPI0714831A2 (pt) 2006-07-18 2013-04-02 Anadys Pharmaceuticals Inc composto, composiÇço farmacÊutica e mÉtodos de modulaÇço de atividades imuno da citoquina em paciente, de tratamento de infecÇço de vÍrus c da hepatite em paciente e de desordem relacionada com proliferaÇço em mamÍfero necessitado do mesmo

Also Published As

Publication number Publication date
CN101365705A (zh) 2009-02-11
JP2009516709A (ja) 2009-04-23
ATE474842T1 (de) 2010-08-15
AU2006318260A1 (en) 2007-05-31
AU2006318260B2 (en) 2012-05-17
ES2345904T3 (es) 2010-10-05
BRPI0618789A2 (pt) 2016-08-30
CA2630463C (en) 2015-01-06
US7781581B2 (en) 2010-08-24
WO2007062355A2 (en) 2007-05-31
IL191568A0 (en) 2008-12-29
EP1973920B1 (en) 2010-07-21
WO2007062355A3 (en) 2007-07-26
NO20082365L (no) 2008-08-18
EP1973920A2 (en) 2008-10-01
TW200736265A (en) 2007-10-01
AR058210A1 (es) 2008-01-23
CA2630463A1 (en) 2007-05-31
DE602006015700D1 (de) 2010-09-02
KR20080090400A (ko) 2008-10-08
JP5117391B2 (ja) 2013-01-16
TWI383987B (zh) 2013-02-01
SG152296A1 (en) 2009-05-29
US20070117979A1 (en) 2007-05-24

Similar Documents

Publication Publication Date Title
EA200600677A1 (ru) 5,7-диаминопиразоло[4,3-d]пиримидины c ингибирующей pde-5 активностью
EA200801372A1 (ru) Способы получения замещенных пиримидинов
WO2007085895A3 (en) Fap inhibitors
WO2007035629A3 (en) Process for the preparation of pyrimidinedione derivatives
EA201000642A1 (ru) 2'-фтор-2'-дезокситетрагидроуридины в качестве ингибиторов цитидиндеаминазы
CL2007003459A1 (es) Proceso de preparacion de compuestos derivados de pirimidina; y compuesto intermediario (s)-trans-etil 3-etoxi-7-(4-(4-fluorofenil)-6-isopropil-2-(n-metilmetilsulfonamido)pirimidin-5-il)-5-hidroxihep-2,6-dienoato.
NO20076371L (no) Fremgangsmate for fremstilling av fenoliske 4-bifenylylazetidin-2-oner
EA201991779A2 (ru) Способы получения ингибиторов jak киназ и родственных промежуточных соединений
ATE427965T1 (de) Antikírper gegen 25-hydroxyvitamin d
EA200800886A1 (ru) Способ получения 1-н-имидазо[4,5-с]пиридинов и их аналогов
EA200800728A1 (ru) Полиморфы бензоатной соли 2-[[6-[(3r)-3-амино-1-пиперидинил]-3,4-дигидро-3-метил-2,4-диоксо-1(2н)-пиримидинил]метил]бензонитрила и способы их применения
EA200801381A1 (ru) Производные пиримидина
NO20074093L (no) Fremgangsmater for fremstilling av glukopyranosyl-substituerte benzyl-benzenderivater og mellomprodukter derav
EA200970519A1 (ru) Полиморфы сукцината 2-[6-(3-аминопиперидин-1-ил)-3-метил-2,4-диоксо-3,4-дигидро-2h-пиримидин-1-илметил]-4-фторбензонитрил и способы их применения
CL2013002895A1 (es) Compuestos derivados de 7,8-dihidro-5h-pteridin-6-ona, utiles como intermediarios en la sintesis de compuestos derivados de pteridinona (divisional de la solicitud 3123-2005).
EA201101004A1 (ru) Фунгицидная композиция
PA8650501A1 (es) Sintesis asimetrica de derivados de dihidrobenzofurano
EA200801404A1 (ru) Новый способ получения 5-амино-3н-тиазоло[4,5-d]пиримидин-2-она
BRPI0509731A (pt) pirazol[4,3-d]pirimidinas
CR8184A (es) Pirimidinas 2-sustituidas
EA201891769A1 (ru) СПОСОБ ПОЛУЧЕНИЯ СОЕДИНЕНИЯ ПИРРОЛО[3,2-d]ПИРИМИДИНА И ПРОМЕЖУТОЧНЫХ СОЕДИНЕНИЙ
DK1831239T3 (da) Fremgangsmåde til fremstilling af 17-hydroxy-6 beta, 7 beta, 15 beta, 16 beta-bismethylen-17alpha-pregn-4-en-3-on-21-carboxylsyre-lambda-lacton og nøgle-mellemprodukter til denne fremgangsmåde
WO2006066044A3 (en) Processes for producing 4-aminoquinazolines
EA200600605A1 (ru) Перегруппированные пентанолы, способ их получения и их применение в качестве противовоспалительных средств
DK1723140T3 (da) Fremgangsmåde til fremstilling af tryptase-inhibitorer